Key terms

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest SYK news

Yesterday 7:23am ET Stryker price target raised to $400 from $365 at TD Cowen Apr 06 5:08am ET Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Novartis AG (Six Swiss: CH:NOVN) and AstraZeneca (GB:AZN) Apr 06 5:05am ET Analysts Offer Insights on Healthcare Companies: Shop Apotheke Europe NV (GB:0RJT), Stryker (SYK) and Novartis AG (Six Swiss: CH:NOVN) Apr 03 5:53am ET Stryker price target raised to $406 from $362 at Citi Feb 23 10:11am ET Stryker price target raised to $380 from $335 at Argus Feb 21 7:25am ET BTIG medical technology analyst to hold analyst/industry conference call Feb 21 4:55am ET BTIG medical technology analyst to hold analyst/industry conference call Feb 15 12:57pm ET BTIG medical technology analyst to hold analyst/industry conference call Feb 15 8:25am ET Stryker (SYK) Poised for Continued Growth: A Strong Buy Recommendation Feb 15 7:02am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Stryker (SYK), SAGE Therapeutics (SAGE) and Healthcare Services (HCSG) Feb 15 6:20am ET Wall Street Analysts Are Bullish on Top Healthcare Picks Feb 14 9:55pm ET Stryker Earns ‘Buy’ Rating on Sustained Procedure Volume and Strategic ASC Dominance Feb 01 7:56am ET Stryker price target raised to $360 from $315 at Canaccord Jan 31 10:10am ET Stryker price target raised to $360 from $345 at RBC Capital Jan 31 9:55am ET Stryker Corporation: A Stable Hold Amidst Strong Financial Performance and Fair Valuation Jan 31 9:55am ET Early notable gainers among liquid option names on January 31st Jan 31 9:53am ET UPS downgraded, Stryker upgraded: Wall Street’s top analyst calls Jan 31 9:38am ET Stryker price target raised to $345 from $300 at Deutsche Bank Jan 31 9:16am ET Stryker’s Strong Q4 Performance and Growth Prospects Warrant a Buy Rating Jan 31 9:15am ET Stryker price target raised to $362 from $340 at Citi Jan 31 9:06am ET Stryker price target raised to $345 from $320 at Morgan Stanley Jan 31 9:03am ET Stryker price target raised to $345 from $330 at Truist Jan 31 8:56am ET Stryker price target raised to $372 from $341 at Barclays Jan 31 8:52am ET Stryker price target raised to $375 from $360 at Piper Sandler Jan 31 8:47am ET Stryker price target raised to $348 from $345 at Roth MKM Jan 31 8:31am ET Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Praxis Precision Medicines (PRAX) and Thermo Fisher (TMO) Jan 31 8:20am ET Analysts Are Bullish on These Healthcare Stocks: Stryker (SYK), Cencora (COR) Jan 31 8:05am ET Stryker’s Stock Buy Rating: Anticipating Strong Financial Performance and Market Outperformance Jan 31 7:34am ET Stryker price target raised to $365 from $322 at TD Cowen Jan 31 7:25am ET Stryker upgraded to Buy from Hold at Canaccord Jan 31 7:13am ET Stryker price target raised to $353 from $325 at BTIG

No recent news articles are available for SYK

No recent press releases are available for SYK

SYK Financials

1-year income & revenue

Key terms

SYK Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

SYK Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms